Answer
Tocilizumab (RoActemra) should not be used during pregnancy unless clearly necessary, as adequate human data are lacking, high-dose animal studies showed increased spontaneous abortion/embryo-foetal death, and the potential human risk is unknown.
Sources for this answer
- RoActemra 20mg/ml Concentrate for Solution for InfusionRoche Products Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 38Document updated
Sources checked